Silo Pharma Stock Investor Sentiment

SILO Stock  USD 1.36  0.02  1.45%   
About 62% of Silo Pharma's investor base is looking to short. The analysis of current outlook of investing in Silo Pharma suggests that many traders are alarmed regarding Silo Pharma's prospects. Silo Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Silo Pharma. Many technical investors use Silo Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a year ago at simplywall.st         
Silo Pharma Third Quarter 2023 Earnings EPS Beats Expectations
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
Silo Pharma Third Quarter 2023 Earnings EPS Beats Expectations - Simply Wall St
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Short Interest in Silo Pharma, Inc. Declines By 15.4
news
over a year ago at thelincolnianonline.com         
Financial Analysis Simon Worldwide vs. Silo Pharma
news
over a year ago at screenrant.com         
Silo Season 2 Wishlist 10 Things We Want To See Happen
news
over a year ago at thelincolnianonline.com         
Head-To-Head Contrast Simon Worldwide and Silo Pharma
news
over a year ago at finance.yahoo.com         
Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment ...
Yahoo News
over a year ago at news.google.com         
Q3 2023 Alto Ingredients Inc Earnings Call - Yahoo Finance
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Comparing Silo Pharma Blue
news
over a year ago at forbes.com         
Inside HEADS KNOW An Event Brand Showcasing Underground, Underrepresented And Rising Artists Through...
Usa forbes News
over a year ago at www.macroaxis.com         
Purchase by Eric Weisblum of 130 shares of Silo Pharma
Macroaxis News
over a year ago at gizmodo.com         
Beacon 23 Looks Like Twisty Sci-Fi Fun With Lena Headey
news
over a year ago at finance.yahoo.com         
Silo Pharmas SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
Yahoo News
over a year ago at news.google.com         
Silo Pharmas SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis - Yahoo Finance
Google News at Macroaxis
over a year ago at globenewswire.com         
Silo Pharmas SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Silo Pharma that are available to investors today. That information is available publicly through Silo media outlets and privately through word of mouth or via Silo internal channels. However, regardless of the origin, that massive amount of Silo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Silo Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Silo Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Silo Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Silo Pharma alpha.

Silo Pharma Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb 020406080100120
JavaScript chart by amCharts 3.21.15Silo Pharma Silo Pharma Dividend Benchmark Dow Jones Industrial
       Timeline  

Other Information on Investing in Silo OTC Stock

Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.
News Freq…Investor S…